Stimulation of interleukin-13 expression by human T-cell leukemia virus type 1 oncoprotein Tax via a dually active promoter element responsive to NF-κB and NFAT
The human T-cell leukemia virus type 1 (HTLV-1) Tax oncoprotein transforms human lymphocytes and is critical for the pathogenesis of HTLV-1-induced adult T-cell leukaemia. In HTLV-transformed cells, Tax upregulates interleukin (IL)-13, a cytokine with proliferative and anti-apoptotic functions that is linked to leukaemogenesis. Tax-stimulated IL-13 is thought to result in autocrine stimulation of HTLV-infected cells and thus may be relevant to their growth. The causal transactivation of the IL-13 promoter by Tax is predominantly dependent on a nuclear factor of activated T cells (NFAT)-binding P element. Here, it was shown that the isolated IL-13 Tax-responsive element (IL13TaxRE) was sufficient to mediate IL-13 transactivation by Tax and NFAT1. However, cyclosporin A, a specific NFAT inhibitor, revealed that Tax transactivation of IL13TaxRE or wild-type IL-13 promoter was independent of NFAT and that NFAT did not contribute to IL-13 upregulation in HTLV-transformed cells. By contrast, Tax stimulation was repressible by an efficient nuclear factor (NF)-κB inhibitor (IkBaDN), indicating the requirement for NF-κB. The capacity of NF-κB to stimulate IL13TaxRE was demonstrated by a strong response to NF-κB in reporter assays and by direct binding of NF-κB to IL13TaxRE. Thus, IL13TaxRE in the IL-13 promoter represents a dually active promoter element responsive to NF-κB and NFAT. Together, these results indicate that Tax causes IL-13 upregulation in HTLV-1-infected cells via NF-κB.
AhlersJ. D.,
BelyakovI. M.,
TerabeM.,
KokaR.,
DonaldsonD. D.,
ThomasE. K.,
BerzofskyJ. A.2002; A push–pull approach to maximize vaccine efficacy: abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte/macrophage colony-stimulating factor and CD40L. Proc Natl Acad Sci U S A 99:13020–13025[CrossRef]
AkagiT.,
OnoH.,
NyunoyaH.,
ShimotohnoK.1997; Characterization of peripheral blood T-lymphocytes transduced with HTLV-I Tax mutants with different trans -activating phenotypes. Oncogene 14:2071–2078[CrossRef]
BargouR. C.,
LengC.,
KrappmannD.,
EmmerichF.,
MaparaM. Y.,
BommertK.,
RoyerH. D.,
ScheidereitC.,
DorkenB.1996; High-level nuclear NF- κ B and Oct-2 is a common feature of cultured Hodgkin/Reed–Sternberg cells. Blood 87:4340–4347
ChungH. K.,
YoungH. A.,
GoonP. K.,
HeideckerG.,
PrinclerG. L.,
ShimozatoO.,
TaylorG. P.,
BanghamC. R.,
DerseD.2003; Activation of interleukin-13 expression in T cells from HTLV-1-infected individuals and in chronically infected cell lines. Blood 102:4130–4136[CrossRef]
DeepakP.,
SanjayK.,
AcharyaA.2007; IL-13 R α 2-mediated interleukin-13 neutralization represses in vivo progressive growth of a T-cell lymphoma. J Exp Clin Cancer Res 26:347–352
DolganovG.,
BortS.,
LovettM.,
BurrJ.,
SchubertL.,
ShortD.,
McGurnM.,
GibsonC.,
LewisD. B.1996; Coexpression of the interleukin-13 and interleukin-4 genes correlates with their physical linkage in the cytokine gene cluster on human chromosome 5q23-31. Blood 87:3316–3326
FarmerP. K.,
HeX.,
SchmitzM. L.,
RubinJ.,
NanesM. S.2000; Inhibitory effect of NF- κ B on 1,25-dihydroxyvitamin D3 and retinoid X receptor function. Am J Physiol Endocrinol Metab 279:E213–E220
FraedrichK.,
MullerB.,
GrassmannR.2005; The HTLV-1 Tax protein binding domain of cyclin-dependent kinase 4 (CDK4) includes the regulatory PSTAIRE helix. Retrovirology 2:54[CrossRef]
FujiiM.,
ChuhjoT.,
MinaminoT.,
MasaakiN.,
MiyamotoK.,
SeikiM.1995; Identification of the Tax interaction region of serum response factor that mediates the aberrant induction of immediate early genes through CArG boxes by HTLV-I Tax. Oncogene 11:7–14
GessainA.,
BarinF.,
VernantJ. C.,
GoutO.,
MaursL.,
CalenderA.,
de TheG.1985; Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2:407–410
GoodL.,
MaggirwarS. B.,
SunS. C.1996; Activation of the IL-2 gene promoter by HTLV-I tax involves induction of NF-AT complexes bound to the CD28-responsive element. EMBO J 15:3744–3750
GoodL.,
MaggirwarS. B.,
HarhajE. W.,
SunS. C.1997; Constitutive dephosphorylation and activation of a member of the nuclear factor of activated T cells, NF-AT1, in Tax-expressing and type I human T-cell leukemia virus-infected human T cells. J Biol Chem 272:1425–1428[CrossRef]
GrossmanW. J.,
KimataJ. T.,
WongF. H.,
ZutterM.,
LeyT. J.,
RatnerL.1995; Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I. Proc Natl Acad Sci U S A 92:1057–1061[CrossRef]
HasegawaH.,
SawaH.,
LewisM. J.,
OrbaY.,
SheehyN.,
YamamotoY.,
IchinoheT.,
Tsunetsugu-YokotaY.,
KatanoH.other authors2006; Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I. Nat Med 12:466–472[CrossRef]
HeinemannS.,
BiesingerB.,
FleckensteinB.,
AlbrechtJ. C.2006; NF κ B signaling is induced by the oncoprotein Tio through direct interaction with TRAF6. J Biol Chem 281:8565–8572[CrossRef]
HinzM.,
LemkeP.,
AnagnostopoulosI.,
HackerC.,
KrappmannD.,
MathasS.,
DorkenB.,
ZenkeM.,
SteinH.,
ScheidereitC.2002; Nuclear factor κ B-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity. J Exp Med 196:605–617[CrossRef]
JeangK. T.2001; Functional activities of the human T-cell leukemia virus type I Tax oncoprotein: cellular signaling through NF- κ B. Cytokine Growth Factor Rev 12:207–217[CrossRef]
JinquanT.,
FrydenbergJ.,
MukaidaN.,
BondeJ.,
LarsenC. G.,
MatsushimaK.,
Thestrup-PedersenK.1995; Recombinant human growth-regulated oncogene-alpha induces T lymphocyte chemotaxis. A process regulated via IL-8 receptors by IFN-gamma, TNF-alpha, IL-4, IL-10, and IL-13. J Immunol 155:5359–5368
KappU.,
YehW. C.,
PattersonB.,
EliaA. J.,
KagiD.,
HoA.,
HesselA.,
TipswordM.,
WilliamsA.other authors1999; Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed–Sternberg cells. J Exp Med 189:1939–1946[CrossRef]
Li-WeberM.,
GiaisiM.,
BaumannS.,
PalfiK.,
KrammerP. H.2004; NF- κ B synergizes with NF-AT and NF-IL6 in activation of the IL-4 gene in T cells. Eur J Immunol 34:1111–1118[CrossRef]
LomoJ.,
BlomhoffH. K.,
JacobsenS. E.,
KrajewskiS.,
ReedJ. C.,
SmelandE. B.1997; Interleukin-13 in combination with CD40 ligand potently inhibits apoptosis in human B lymphocytes: upregulation of Bcl-xL and Mcl-1. Blood 89:4415–4424
NeuveutC.,
LowK. G.,
MaldarelliF.,
SchmittI.,
MajoneF.,
GrassmannR.,
JeangK. T.1998; Human T-cell leukemia virus type 1 Tax and cell cycle progression: role of cyclin D-cdk and p110Rb. Mol Cell Biol 18:3620–3632
NiinumaA.,
HiguchiM.,
TakahashiM.,
OieM.,
TanakaY.,
GejyoF.,
TanakaN.,
SugamuraK.,
XieL.other authors2005; Aberrant activation of the interleukin-2 autocrine loop through the nuclear factor of activated T cells by nonleukemogenic human T-cell leukemia virus type 2 but not by leukemogenic type 1 virus. J Virol 79:11925–11934[CrossRef]
PeloponeseJ. M.,
YeungM. L.,
JeangK. T.2006; Modulation of nuclear factor- κ B by human T cell leukemia virus type 1 Tax protein: implications for oncogenesis and inflammation. Immunol Res 34:1–12[CrossRef]
PichlerK.,
KattanT.,
GentzschJ.,
KressA. K.,
TaylorG. P.,
BanghamC. R.,
GrassmannR.2008; Strong induction of 4-1BB, a growth and survival promoting costimulatory receptor, in HTLV-1-infected cultured and patients' T-cells by the viral Tax oncoprotein. Blood 111:4741–4751[CrossRef]
PoieszB. J.,
RuscettiF. W.,
GazdarA. F.,
BunnP. A.,
MinnaJ. D.,
GalloR. C.1980; Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 77:7415–7419[CrossRef]
PrinclerG. L.,
JuliasJ. G.,
HughesS. H.,
DerseD.2003; Roles of viral and cellular proteins in the expression of alternatively spliced HTLV-1 pX mRNAs. Virology 317:136–145[CrossRef]
RelicB.,
GuicheuxJ.,
MezinF.,
LubbertsE.,
TogninalliD.,
GarciaI.,
van den BergW. B.,
GuerneP. A.2001; IL-4 and IL-13, but not IL-10, protect human synoviocytes from apoptosis. J Immunol 166:2775–2782[CrossRef]
RiveraI.,
HarhajE. W.,
SunS. C.1998; Involvement of NF-AT in type I human T-cell leukemia virus Tax-mediated Fas ligand promoter transactivation. J Biol Chem 273:22382–22388[CrossRef]
RomanchikovaN.,
IvanovaV.,
SchellerC.,
JankevicsE.,
JassoyC.,
SerflingE.2003; NFAT transcription factors control HIV-1 expression through a binding site downstream of TAR region. Immunobiology 208:361–365[CrossRef]
RubenS. M.,
DillonP. J.,
SchreckR.,
HenkelT.,
ChenC. H.,
MaherM.,
BaeuerleP. A.,
RosenC. A.1991; Isolation of a rel -related human cDNA that potentially encodes the 65-kD subunit of NF- κ B. Science 251:1490–1493[CrossRef]
SchmittI.,
RosinO.,
RohwerP.,
GossenM.,
GrassmannR.1998; Stimulation of cyclin-dependent kinase activity and G1- to S-phase transition in human lymphocytes by the human T-cell leukemia/lymphotropic virus type 1 Tax protein. J Virol 72:633–640
SerflingE.,
Berberich-SiebeltF.,
ChuvpiloS.,
JankevicsE.,
Klein-HesslingS.,
TwardzikT.,
AvotsA.2000; The role of NF-AT transcription factors in T cell activation and differentiation. Biochim Biophys Acta14981–18[CrossRef]
SharmaS.,
MamaneY.,
GrandvauxN.,
BartlettJ.,
PetropoulosL.,
LinR.,
HiscottJ.2000; Activation and regulation of interferon regulatory factor 4 in HTLV type 1-infected T lymphocytes. AIDS Res Hum Retroviruses 16:1613–1622[CrossRef]
SharmaS.,
GrandvauxN.,
MamaneY.,
GeninP.,
AzimiN.,
WaldmannT.,
HiscottJ.2002; Regulation of IFN regulatory factor 4 expression in human T cell leukemia virus-I-transformed T cells. J Immunol 169:3120–3130[CrossRef]
SilbermannK.,
GrassmannR.2007; Human T cell leukemia type 1 Tax-induced signals in cell survival, proliferation, and transformation. Signal Transduct 7:34–52[CrossRef]
SkinniderB. F.,
EliaA. J.,
GascoyneR. D.,
TrumperL. H.,
von BoninF.,
KappU.,
PattersonB.,
SnowB. E.,
MakT. W.2001; Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed–Sternberg cells of Hodgkin lymphoma. Blood 97:250–255[CrossRef]
SmithM. R.,
GreeneW. C.1990; Identification of HTLV-I tax trans -activator mutants exhibiting novel transcriptional phenotypes. Genes Dev 4:1875–1885[CrossRef]
StuverS. O.,
TachibanaN.,
OkayamaA.,
MuellerN. E.1996; Evaluation of morbidity among human T lymphotropic virus type 1 carriers in Miyazaki. Jpn J Infect Dis 173:584–591[CrossRef]
TerabeM.,
MatsuiS.,
Noben-TrauthN.,
ChenH.,
WatsonC.,
DonaldsonD. D.,
CarboneD. P.,
PaulW. E.,
BerzofskyJ. A.2000; NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat Immunol 1:515–520[CrossRef]
WäldeleK.,
SilbermannK.,
SchneiderG.,
RuckesT.,
CullenB. R.,
GrassmannR.2006; Requirement of the human T-cell leukemia virus (HTLV-1) tax-stimulated HIAP-1 gene for the survival of transformed lymphocytes. Blood 107:4491–4499[CrossRef]
YoshidaM.,
SeikiM.,
YamaguchiK.,
TakatsukiK.1984; Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci U S A 81:2534–2537[CrossRef]
YuC. R.,
KirkenR. A.,
MalabarbaM. G.,
YoungH. A.,
OrtaldoJ. R.1998; Differential regulation of the Janus kinase–STAT pathway and biologic function of IL-13 in primary human NK and T cells: a comparative study with IL-4. J Immunol 161:218–227
Stimulation of interleukin-13 expression by human T-cell leukemia virus type 1 oncoprotein Tax via a dually active promoter element responsive to NF-κB and NFAT